ClinicalTrials.gg
Drug

Ferric citrate clinical trials

Also written KRX-0502.

Includes 4 studies of Tetraferric tricitrate decahydrate.

studies test it
23
open now
1
in phase 3
12
first study started
2008

How each study uses ferric citrate is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the ferric citrate studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
5 Sept 2014 · AURYXIA · NDA 205874 (FDA, Drugs@FDA; as tetraferric tricitrate decahydrate)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Ferric Citrate
17
Auryxia
7

Development codes

KRX-0502
7

Studies by the year they started

23 studies that test it; most in 2017 (4)

Studies that test ferric citrate, by start year
YearStudies
20081
20102
20122
20142
20152
20161
20174
20192
20201
20211
20223
20251
20261

By phase

A phase 1/2 study counts in both.

Phase 2
4
Phase 3
12
Phase 4
6
No phase
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 14 · Other 9

Keryx Biopharmaceuticals (9) · Panion & BF Biotech Inc. (4) · USRC Kidney Research (2) · University of California, Los Angeles (1) · Sreedhar Mandayam (1) · Sinomune Pharmaceutical Co., Ltd (1) · Kaiser Permanente (1) · University of Alabama at Birmingham (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 2, 1 in phase 3

Studies that test ferric citrate, phase 3 first.

Studies

Open first, then newest update. How each study uses ferric citrate is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 23

See all 23 studies that test ferric citrate →

Given beside what is tested · 1 — ferric citrate is usual care or a partner of the new treatment

Codes

What other systems call ferric citrate · ClinicalTrials.gg INT002810

  • MeSH (NLM) C025314ferric citrateConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) 63G354M39ZFERRIC CITRATE ANHYDROUSOne source NLM
  • RxNorm 1594675One source FDA

Also registered as ferric citrate dihydrate (UNII R6V6N63VUJ) and ferric citrate trihydrate (UNII 756B6D74H4).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.